Although several studies have shown that CEA, CA-125, and Cyfra21-1 are prognostic factors for stage III-IV non-small cell lung cancer, (Zhang et al., 2015; Chen et al., 2018) they did not investigate the liver metastasis of lung cancer. This evidence concerns the gene CEACAM5 and lung carcinoma.